top of page
Our insights on the latest trends across Medicaid, Medicare, and Commercial Payers.
We offer grounded perspectives on how the healthcare market is shifting, shaped by real work with health plans, healthtech teams, and industry partners. Our insights surface what’s changing, where friction is emerging, and how different stakeholders can respond with greater alignment, rigor, and impact.

The Akros Advantage: GTM Insights Delivered Straight to Your Inbox
Don’t miss what’s next in HealthTech. Subscribe to the Akros Advantage for fresh payer insights, upcoming events, practical tools to help your solution scale, and more from the Akros team.


The ROI Reality Check: Why Payer-Market Fit Requires More Than Clinical Value
Clinical outcomes alone are no longer enough to secure payer contracts. As health plans and employers place greater emphasis on measurable financial returns, HealthTech companies must demonstrate credible ROI, align with buyer priorities, and prepare for performance-based contracting. Explore what this shift means for payer-market fit and how founders can build a stronger business case for adoption.


Hard vs. Soft Benefits: Is Your Value Proposition Strong Enough for a Payer?
Use Akros’ Hard vs. Soft Benefits Tool to map your solution’s outcomes, understand how payers may value them, and identify the evidence needed to build a stronger, more defensible value proposition.


2026 Payer Strategy and Market Opportunity Insights
Use Akros’ latest payer strategy maps to see where major health plans are growing, investing, partnering, and pulling back, and identify the market opportunities those shifts may create for HealthTech companies.


Q2 2026 Top Five Payer Earnings Strategic Insights
Explore how major payers are building, buying, investing, and partnering across healthcare to identify the capabilities they value and where your solution may fit within their strategic priorities.


A Case Study for Health Plan Leaders: Reframing Women’s Health as a Value Strategy
Learn how health plans can look beyond traditional claims analysis to uncover overlooked opportunities for innovation, improve outcomes, and reduce costs—even when claims data captures only part of the patient journey.


SDOH Then and Now: Building a GTM Strategy That Works
Learn how SDOH companies can build a stronger go-to-market strategy by choosing the right buyer, aligning with real healthcare workflows, identifying funding pathways, and proving measurable outcomes and ROI.


Food Is Medicine: The Latest Scoop on Policy, Evidence, and How to Choose the Right Partner
Learn how health plans can build scalable Food Is Medicine programs by matching interventions to member needs, integrating accountable delivery partners, and using measurable outcomes to demonstrate clinical and financial value.


Navigating Regulatory Uncertainty: U.S. GTM Strategy and Legal Structure for International HealthTech Founders
Expanding into the U.S. healthcare market requires aligning legal structure, compliance readiness, and payer strategy in a way that supports long-term growth. This workshop is designed to help leaders make the foundational decisions that increase credibility with payers, providers, and investors from the outset.


The New ERISA Risk: What Self-Funded Employers Can Do to Protect Themselves
ERISA creates both opportunities and complexity for healthcare organizations serving self-funded employers. This webinar breaks down how ERISA shapes plan design, financial risk, and decision-making, and what healthcare leaders need to understand when working with employer-sponsored health plans.


To Code or Not To Code
Reimbursement strategy can shape how a digital health solution reaches the market. This workshop explores traditional and non-traditional reimbursement pathways, when existing or new codes may make sense, and how founders can evaluate alternative funding models based on their technology and target market.


Winning with Quality: How HEDIS & Stars Drive Payer Decisions
Quality performance has a direct impact on health plan outcomes, member experience, and financial performance. This webinar explores how health plans can strengthen quality strategy, align investments with measurable goals, and use data and cross-functional collaboration to drive sustainable improvement.


The Big Beautiful Bill: What HR 1 Really Means for Medicaid in 2026
Policy changes from the One Big Beautiful Bill could reshape how families access critical safety net benefits, creating new challenges for health plans to address administrative barriers, coverage gaps, and the financial factors that influence member health.


How U.S. Health Plans Outsourced Their Core and What It Means for the Future of Payers
I was walking the exhibit floor at Becker’s, weaving through the noise of bright booths and polished sales pitches, when something unusual stopped me. A vendor was promoting a platform designed to help health plans manage product and benefit data. Automation, compliance support, efficiency gains. Nothing surprising on the surface. Then the realization landed with a kind of somber force. If a payer cannot manage its own product and benefit data (i.e. the foundational function


The Ripple Effects of Semiannual Reporting for Digital Health Tech Founders: CFO, Actuarial, and Sales Cycle Dynamics
Inside health plans, the proposed change to semiannual reporting may rewire the clockwork of financial, actuarial, and commercial decision-making. For digital health tech founders, understanding these internal clocks isn’t optional. It’s how you time your outreach, structure your pilots, and shape the proof points you deliver. If you know when payers make decisions, you stop knocking on closed doors and start arriving exactly when they open. Let’s take a look at the three int


Building an Innovation Capital Model That Breaks the Quarter-to-Quarter Cycle
Semiannual reporting offers more than a compliance shift. It extends an opening for payers to rethink not only what they invest in, but how they invest. Semiannual reporting won’t, on its own, change the cadence of actuarial or finance cycles, since those teams will continue running on their own internal timelines. But the shift creates breathing room, allowing for executives to reframe how capital is allocated and how innovation is judged. Traditional capital frameworks a
bottom of page